EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

The development of ovarian carcinosarcoma from serous tubal intraepithelial carcinoma: an immunohistochemical case report with literature review

Paula Szlendak, Dorota Lewkowicz, Andrea Romano, Marek Semczuk, Maciej Jóźwik, Andrzej Semczuk

Frontiers in Oncology · 15.04.2026 · 16

DOI: 10.3389/fonc.2026.1727634 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 15.04.2026. Verfasst von Paula Szlendak und 5 weiteren Autor:innen. Beteiligte Einrichtung: IIDepartment of Gynecological Surgery and Gynecological Oncology, Lublin Medical University, Lublin, Poland. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian carcinosarcoma (OCS) is an uncommon and highly aggressive subtype of ovarian carcinoma characterized by the simultaneous occurrence of two malignant components: carcinomatous and sarcomatous. Located at the fimbrial region of the fallopian tube, serous tubal intraepithelial carcinoma (STIC) represents a form of precursor lesion for high-grade serous carcinoma (HGSC). In the current report, we present an intriguing case study of left OCS concomitant with ipsilateral STIC. Immunohistochemical (IHC) assessment showed a similar staining pattern of the carcinomatous OCS component and STIC. In conclusion, the development of OCS from STIC should be considered. Such a situation represents both a rare phenomenon and a challenge for preoperative diagnostic protocol. A careful application of selected IHC markers, p53 and Ki-67 in particular, may substantially help not only in the differential diagnosis but also in clinicopathological algorithms based on OCS molecular profiling into HGSC-like and non-HGSC-like variants.

Schlagwörter

Stichwörter der Autor:innen

Ki-67immunohistochemistryovarian carcinosarcomap53serous tubal intraepithelial carcinoma

Autor:innen und Institutionen

  • IIDepartment of Gynecological Surgery and Gynecological Oncology, Lublin Medical University, Lublin, Poland.
  • Department of Pathology, Lublin Medical University, Lublin, Poland.
  • Department of Gynecology, Maastricht University Medical Centre (MUMC), Maastricht, Netherlands.
  • Department of Gynecology and Gynecologic Oncology, Medical University of Białystok, Białystok, Poland.

Zitieren

APA

Szlendak, P., Lewkowicz, D., Romano, A., Semczuk, M., Jóźwik, M., & Semczuk, A. (2026). The development of ovarian carcinosarcoma from serous tubal intraepithelial carcinoma: an immunohistochemical case report with literature review. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1727634

Vancouver

Szlendak P, Lewkowicz D, Romano A, Semczuk M, Jóźwik M, Semczuk A. The development of ovarian carcinosarcoma from serous tubal intraepithelial carcinoma: an immunohistochemical case report with literature review. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1727634

BibTeX
@article{Szlendak2026,
  author = {Szlendak, Paula and Lewkowicz, Dorota and Romano, Andrea and Semczuk, Marek and Jóźwik, Maciej and Semczuk, Andrzej},
  title = {The development of ovarian carcinosarcoma from serous tubal intraepithelial carcinoma: an immunohistochemical case report with literature review},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1727634}
}
Kostenlos starten →